Literature DB >> 8766865

In vitro effects of some differentiation inductors in metaplastic epithelium of the human nasal cavity.

M Gulisano1, S Pacini, M Ruggiero, A Pacini, A N Delrio, P Pacini.   

Abstract

The alterations in the mucociliary unit in the course of chronic inflammation of the upper respiratory tract correspond to morphologic anomalies of the respiratory epithelium and induce cuboidal and squamous metaplasia. While the squamous pattern is most probably irreversible, it is still not clear whether it is possible to restore ciliogenesis in cuboidal metaplasia. In the present study, the action of different inductors of differentiation was evaluated in vitro in isolated cells and explants from human nasal metaplastic epithelium. Polar/apolar compounds induced secretory activity, whereas retinoic acid was able to induce ciliogenesis in some cases. Therefore, the cuboidal metaplastic condition appears to be reversible, and two distinct pathways of differentiation, secretory and ciliogenetic, are identifiable.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8766865     DOI: 10.1007/s004410050627

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  3 in total

1.  Histopathological changes in nasal mucosa with nasal septum deviation.

Authors:  Tawakir Kamani; Taner Yılmaz; Selçuk Sürücü; Münir Demir Bajin; Rıza Önder Günaydın; Oğuz Kuşçu
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-20       Impact factor: 2.503

2.  Staphylococcus aureus adherence to nasal epithelial cells in a physiological in vitro model.

Authors:  A Hoefnagels-Schuermans; W E Peetermans; M Jorissen; S Van Lierde; J van den Oord; R De Vos; J Van Eldere
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-09       Impact factor: 2.416

3.  Ciliogenesis in submersion and suspension cultures of human nasal epithelial cells.

Authors:  Peter Neugebauer; Heike Endepols; Axel Mickenhagen; Martin Walger
Journal:  Eur Arch Otorhinolaryngol       Date:  2002-12-11       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.